KIZZY PETERSEN: Open Payments
NPI 1457732414 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 19 payments from 9 companies in 2025. Trend: 2023 $450 · 2024 $253 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
Products named: VRAYLAR, TRINTELLIX, REXULTI, HETLIOZ, ABILIFY MAINTENA, INGREZZA, Auvelity, COBENFY.
Industry payments across NC — which companies pay providers there.
